Formulation optimization of itraconazole loaded PEGylated liposomes for parenteral administration by using design of experiments

被引:43
作者
Curic, Anamarija [1 ,2 ]
Reul, Regina [1 ]
Moeschwitzer, Jan [1 ]
Fricker, Gert [2 ]
机构
[1] AbbVie Deutschland GmbH & Co KG, D-67061 Ludwigshafen, Germany
[2] Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany
关键词
PEGylated liposomes; Itraconazole; Design of experiments; Response surface methodology; Six-sigma; WATER-SOLUBLE DRUGS; DELIVERY; STRATEGIES;
D O I
10.1016/j.ijpharm.2013.03.029
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The aim of this study was to systematically characterize and optimize the encapsulation process of itra-conazole (ITZ) into the PEGylated liposomes. ITZ was used as a model compound for poorly soluble drugs. PEGylated liposomes were prepared using the film hydration method combined with sonication in order to produce small unilamellar vesicles (SUV). The concentration of encapsulated ITZ was measured by a reversed phase-high-performance liquid chromatography (RP-HPLC) method. Systematic characterization of encapsulation process was performed using the design of experiments (DoE) approach. The systematic screening of process parameters and well designed settings of parameter levels in optimization phase improved the ITZ encapsulation process. Optimization demonstrated that only minimal range of design space could be used to achieve the highest encapsulation efficiency (EE (%)), more precisely the EE of 90% was gained using 25 mg/ml of lipid and drug loading of 0.3% (w/w). However, the desirable drug loading could be predicted and adjusted by using mathematical modeling behind the DoE approach. The entire encapsulation process was shown to be repeatable with high significance (p < 0.05). It could be demonstrated that DoE plays an important role in optimization experiments leading to robust results supporting high quality. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:189 / 197
页数:9
相关论文
共 25 条
[1]
[Anonymous], 2009, DESIGN ANAL EXPT
[2]
[Anonymous], 2009, Int. J. Drug Delivery Technol, DOI [10.25258/ijddt.v1i2.8839, DOI 10.25258/IJDDT.V1I1.8834]
[3]
Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice [J].
Atyabi, Fatemeh ;
Farkhondehfai, Anahita ;
Esmaeili, Farnaz ;
Dinarvand, Rassoul .
ACTA PHARMACEUTICA, 2009, 59 (02) :133-144
[4]
Protein encapsulation in liposomes: Efficiency depends on interactions between protein and phospholipid bilayer [J].
Colletier J.-P. ;
Chaize B. ;
Winterhalter M. ;
Fournier D. .
BMC Biotechnology, 2 (1)
[5]
Francois M, 2003, AAPS PHARMSCI, V5
[6]
FROMTILING R A, 1988, Clinical Microbiology Reviews, V1, P187
[7]
Goupy Jacques., 2007, INTRO DESIGN EXPT JM
[8]
Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity [J].
Gubernator, Jerzy .
EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (05) :565-580
[9]
Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries [J].
Huelsermann, Uta ;
Hoffmann, Michael M. ;
Massing, Ulrich ;
Fricker, Gert .
JOURNAL OF DRUG TARGETING, 2009, 17 (08) :610-618
[10]
Immordino ML, 2006, INT J NANOMED, V1, P297